Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Managing Medication Shortages of Life-Saving Oncologic Therapeutics
lungcanc
The Role for Trimodality Therapy in Stage III NSCLC
lungcanc
Exploring Barriers to Combined-Modality Therapy for LS-SCLC
lungcanc
Dr. Howard ‘Skip’ Burris III Shares His Views on Clinical Trial...
lungcanc
FDA Fosters Understanding about Approval Process for Biosimilars
lungcanc
Oncologic Biologic Biosimilars Are Coming to Market: Are You Ready?
lungcanc
Breaking News Briefs
lungcanc
AACR 2018: First-Line Management of Advanced NSCLC Enters New Era
lungcanc
PD-L1 IHC Blueprint Project: Ongoing Progress Toward Consistency Among Assays
lungcanc
2017 Lung Cancer SPORE Workshop
lungcanc
1
...
25
26
27
...
53
Page 26 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
